Special Drug Use Investigation for LAMICTAL Bipolar
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance study is designed to collect and assess information on
safety and effectiveness of lamotrigine tablets in patients with bipolar disorder in routine
clinical practice.
("LAMICTAL" is a trademark of the GlaxoSmithKline group of companies.)